منابع مشابه
Resistance to HER2-targeted therapy
Production and approval of trastuzumab (Herceptin®) for the treatment of metastatic breast cancer (MBC) was a millstone in antibody-based targeted therapy in the cancer treatment. However, despite the early success in the clinical trials, trastuzumab failed to appreciate the initial attraction due to development of resistance to the drug. The majority of patients who benefit from the drug...
متن کاملTargeted cancer therapy: review article
Cancer is one of the most dangerous health problems of today modern societies which has an increasing rate especially in developing countries. There are many diverse ongoing treatment attempts trying to defeat cancer. Despite that, scientists have been unable to find a permanent cure for this disease. In many cases although there is a successful first response in patients, cancer cells are fina...
متن کامل[BRAF mutation: a novel approach in targeted melanoma therapy].
The incidence of malignant melanoma is increasing worldwide, despite our best efforts in prevention and early detection. The locally advanced disease may be treated surgically with good results, however, metastatic melanoma is considered to be one of the most therapeutically challenging malignancies. The increasing knowledge of molecular changes in melanoma may change this picture. Malignant me...
متن کاملTargeted therapy and the T315I mutation in Philadelphia-positive leukemias.
T he deregulated tyrosine kinase activity of the Bcr–Abl chimeric protein, resulting from the t(9;22)(q34;q11) chromosomal translocation on the 22q-derivative – most commonly referred to as the Philadelphia (Ph) chromosome – is responsible for initiation and maintenance of 95% of chronic myeloid leukemias (CML) and 30% of acute lymphoblastic leukemias (ALL) and represents an extremely attractiv...
متن کاملMutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma
INTRODUCTION Advances in the biology of non-small-cell lung cancer, especially adenocarcinoma, reveal multiple molecular subtypes driving oncogenesis. Accordingly, individualized targeted therapeutics are based on mutational diagnostics. AREAS COVERED Advances in strategies and techniques for individualized treatment, particularly of adenocarcinoma, are described through literature review. Ap...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2017
ISSN: 1759-4774,1759-4782
DOI: 10.1038/nrclinonc.2017.108